Latest Strategy News

Starpharma reports steady progress in its DEP® drug development programs, launches new marketing campaigns in key regions, and maintains a strong cash position of $17.2 million as it refines clinical strategies and partnerships.

Infinity Mining Limited reported a challenging quarter with net cash outflows from operations and investing, but bolstered its liquidity through a $1.87 million equity raise and plans to divest Western Australian projects.

Uvre Limited reported steady progress in its uranium and lithium exploration projects during the March 2025 quarter, completing Phase 2 geophysical surveys and advancing joint venture discussions while maintaining solid cash reserves.

Medallion Metals has advanced negotiations to acquire the Cosmic Boy Process Plant at Forrestania, while delivering robust drilling results at Ravensthorpe and securing a $6.5 million placement to fund its sulphide development strategy.

Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.

TG Metals Limited has secured an 80% stake in the Van Uden Gold Project in Western Australia, setting the stage for renewed exploration and resource evaluation. The company is poised to unlock near-term production potential through drilling and stockpile assessments.

Adherium Limited reports a surge in US commercial patients for its Hailie Smartinhaler platform, alongside strategic hires and a new product launch compatible with AstraZeneca inhalers, underpinning plans for a capital raise.

Kingsrose Mining advances its Fennoscandian exploration with high-grade discoveries and strategic acquisition of the Jakon project, supported by robust funding from BHP.

Vanadium Resources Limited has extended its EPC and financing MOU with China Energy and raised A$783,000 via convertible notes, supporting ongoing development of its Steelpoortdrift Vanadium Project amid cost controls and regulatory progress.

PEXA has achieved a crucial regulatory milestone with FCA approval to operate as an Authorised Payment Institution in the UK, paving the way for its Sale & Purchase product launch later this year.

Beonic Limited reported a 6.5% increase in annual recurring revenue to $17.8 million and a significant gross margin improvement to 75.5%, driven by new global contracts and disciplined cost management. The company targets cash flow breakeven in Q4 FY25 and an EBITDA margin of up to 15%.

Axel REE Limited advances its flagship Caladão REE-Gallium Project with significant high-grade intercepts and begins a maiden Mineral Resource Estimate, backed by $9.6 million in cash and strategic government partnerships.